Felix Kind
4PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Dec 05, 2025
Prognostic value of whole-body tumor SUV dispersion on baseline PSMA PET prior to PSMA radioligand therapy.Felix Kind, Ursula Nemer, Katia Brüggemann
|Apr 14, 2025
The Ectonucleotidases CD39 and CD73 and the Purinergic Receptor P2X4 Serve as Prognostic Markers in Non-Small Cell Lung Cancer.Konrad Kurowski, Sophie Nicole Prozmann, António Eduardo Cabrita Figueiredo
|Apr 11, 2022
Bone marrow impairment during early [177Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression?Felix Kind, Kerstin Michalski, Elham Yousefzadeh-Nowshahr
|Jan 11, 2022
Early PSA Change after [177Lu]PSMA-617 Radioligand Therapy as a Predicator of Biochemical Response and Overall Survival.Felix Kind, Thomas F Fassbender, Geoffroy Andrieux
Pageof 1
